Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Vanderbilt-Ingram Breast Cancer Leaders Named Komen Scholars


 

Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research.

She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen, the world's largest breast cancer organization.

Since its founding in 1982, Susan G. Komen has funded more than $956 million in research and provided $2.1 billion for screening, education, treatment and psychosocial support for patients and families in 60 countries.

Mayer and Dornan are among 10 new members of the prestigious Komen Scholars advisory group chosen for their knowledge, leadership and contributions to breast cancer research. The Komen Scholars lead and participate as reviewers in Komen's scientific peer review process and serve as experts for Komen's nationwide network of affiliates around the globe.

"I am pleased and honored to be selected for this vitally important role in support of breast cancer research," Mayer said. "The Komen Scholars help select and review the most innovative research projects for the benefit of patients."

Mayer is leader of VICC's Breast Cancer Specialized Program of Research Excellence (SPORE), a research grant program funded by the National Cancer Institute (NCI). She also has served as principal investigator for more than 80 clinical research trials for new therapies and frequently is invited to present her research findings at international cancer conferences.

Mayer received her medical degree from the Federal University of Sáo Paulo, Brazil and came to the United States for her post-graduate training, including internship, residency, chief-residency and Hematology/ Oncology fellowship at the University of Illinois at Chicago.

She joined the Vanderbilt University Medical Center faculty in 2003 and completed her Master of Science in Clinical Investigation degree at Vanderbilt University.

Since then, her research endeavors have been focused on the identification of targetable pathways in breast cancer and mechanisms of resistance to breast cancer therapies, and have been funded by grants and awards from the NCI, SU2C/AACR, and the Breast Cancer Research Foundation (BCRF).

In addition to her leadership at VICC, Mayer has been an active member of the ECOG-ACRIN Breast Core Committee, and the VICC representative of the National Comprehensive Cancer Network (NCCN) Breast Cancer Panel of Experts. She has also been highly involved with the Translational Breast Cancer Research Consortium (TBCRC), and since 2009, has served as co-chair of the TBCRC Endocrine Resistance Working Group (ERWG).

Wayne Dornan from Smyrna, Tennessee, is a former academic dean and clinical neuroscience expert who spent 35 years as a research academic. Specializing in research design and statistical analyses, he was a principal investigator on numerous Phase II and III clinical trials and was awarded more than $5 million in research grants for his work in neuroscience.

In 2008, his life was turned upside down when he was diagnosed with invasive ductal carcinoma breast cancer. Since retiring from academia in 2015, he published a book, "How I Survived Breast Cancer: An Inspirational Journey of Hope and Fact."

He has become an active advocate for patient issues related to breast cancer treatment and research, working regionally and nationally with men and women who are breast cancer survivors. He is a frequent speaker at awareness events and shares his message that "men can get breast cancer, too."

He currently serves as a Cancer Research Advocate for the NCI and an Affiliate Advocate Member for the American Association for Cancer Research (AACR).

Dornan has become an active Susan G. Komen volunteer, serving in numerous roles ranging from lobbying efforts to patient/research advocacy as a member of the Komen Advocacy Advisory Taskforce (KAAT), and as a grant reviewer.

In 2016, he was recognized as the Breast Cancer Survivor of the Year by the Central Tennessee Komen affiliate.

"As a breast cancer survivor, I have a deep-rooted passion and connection with the Susan G. Komen mission of "someday living in a world without breast cancer" and will work relentlessly to play a major role in achieving this goal," Dornan said.

Share:

 

Email Print

 

More Grand Rounds:

 

New Provider Stability Law Takes Effect

New Provider Stability Law Takes Effect

A new Tennessee law that went into effect on Jan. 1 requires more transparency and limits changes to reimbursement rates in contracts between health insurance companies and healthcare providers during a contract term.

Read More

Council Taps Schlacter to Lead Fellows, Adds Two

Council Taps Schlacter to Lead Fellows, Adds Two

As 2018 was winding down, the Nashville Health Care Council promoted one and announced two new additions to the team.

Read More

Parker to Lead Medical Affairs for Envision Physician Services

Parker to Lead Medical Affairs for Envision Physician Services

Rebecca Parker, MD, FACEP, has been tapped to serve as chief medical affairs officer for Envision Physicians Services. In this role, she will focus on health policy, advocacy, government affairs, leadership development, education and public relations.

Read More

C-Suite Appointments at Envision

C-Suite Appointments at Envision

In other news from Envision Healthcare, the Nashville-based company announced appointments of a new chief financial officer and chief information officer.

Read More

Let's Give Them Something to Talk About!

Let's Give Them Something to Talk About!

Awards, Honors, Achievements

Read More

South College Nashville Launches OTA Program

South College Nashville Launches OTA Program

Regionally accredited higher education institution continues to expand health care programs

Read More

Wishes Granted

Saint Thomas Medical Partners recently received a Health Disparities Grant award of $8,420 from the State of Tennessee Minority Health Division.

Read More

Business Briefs

Business Briefs

Ardent Health Services filed initial public offering papers last month in advance of taking the company public. The hospital company, led by CEO David Vandewater, was originally founded as Behavioral Healthcare Corporation in 1993 but had sold off its behavioral hospitals by 2005 as the focus turned solely to acute care.

Read More

TriStar Horizon, Natchez Medical Associates Welcomes Kelsey

TriStar Horizon, Natchez Medical Associates Welcomes Kelsey

TriStar Horizon Medical Center recently welcomed Scott Kelsey, MD, to TriStar Medical Group Natchez Medical Associates. Kelsey has over 20 years of practice experience as a board certified general surgeon.

Read More

Council Fellows Announces 2019 Class

Last month, officials with the Nashville Health Care Council, alongside former U.S. Senate Majority Leader William H. Frist, MD, and healthcare economist Larry Van Horn, announced the 2019 class of the Nashville Health Care Council Fellows.

Read More

Insight Genetics Launches Novel TNBC Test

Last month, Nashville-based Insight Genetics, Inc. announced the launch of its proprietary Insight TNBCtype™, a new test for categorizing triple negative breast cancer (TNBC) tumors into distinct molecular subtypes through its wholly owned CLIA- and CAP-accredited lab, Insight Molecular Labs.

Read More

Newly Published Data Demonstrates Amifostine Delayed The Onset Of Acute Esophagitis For Small Cell Lung Cancer Patients

Newly Published Data Demonstrates Amifostine Delayed The Onset Of Acute Esophagitis For Small Cell Lung Cancer Patients

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical and services company, announce a new publication in Lung Cancer: Targets and Therapy of a contemporary retrospective series showing that subcutaneous amifostine administered before radiotherapy postponed the onset of acute esophagitis in stage 3 small cell lung cancer patients treated with concomitant doublet chemotherapy and hyperfractionated radiotherapy.

Read More

Lipscomb Launches MHA Program

Last month, Lipscomb University officials announced the launch of Nashville's first Master of Health Administration program. The new MHA program is specifically designed to help mid-careerist build their skill set for healthcare leadership roles through an integrated, interactive, immersive curriculum.

Read More

Lewis Joins Tivity Health

Lewis Joins Tivity Health

Veteran healthcare exec Tommy Lewis has joined Tivity Health as senior vice president overseeing investor relations.

Read More

VUSN Receives $1.43 Million to Develop Sexual Assault Nurse Examiner Education

VUSN Receives $1.43 Million to Develop Sexual Assault Nurse Examiner Education

Last month, officials with Vanderbilt University School of Nursing announced the school has received a $1.43 million award from the U.S. Health Resources and Services Administration (HRSA) to develop and implement a Sexual Assault Nurse Examiner (SANE) education program for emergency nurse practitioner (ENP) students.

Read More

Let's Give Them Something to Talk About!

Let's Give Them Something to Talk About!

Linda Brady, MD, a pediatrician with Old Harding Pediatrics and Monroe Carell Jr. Children's Hospital at Vanderbilt, was selected as recipient of the national 2018 Excellence in Diagnosis (V-RED) Award from the Vasculitis Foundation.

Read More

Dolan Taking Helm of Launch Tennessee

Dolan Taking Helm of Launch Tennessee

Margaret Dolan, CPA, MBA, has been tapped to succeed Charlie Brock as president and CEO of Launch Tennessee. Most recently, she was a principal at consulting firm neil Strategies llc.

Read More

Centerstone Appoints Rhodes Foundation President

Centerstone Appoints Rhodes Foundation President

Officials with community-based mental health and addiction services provider Centerstone recently announced that Ramona Rhodes has been named president of Centerstone's Foundation.

Read More

Robbins Joins Saint Thomas Heart

Robbins Joins Saint Thomas Heart

Interventional cardiologist Mark Robbins, MD, recently joined the Saint Thomas Heart team and Ascension Saint Thomas West Hospital. His clinical expertise includes coronary heart disease, peripheral vascular disease, and structural heart.

Read More

VUSN Names Johnson Assistant Dean, Diversity & Inclusion

VUSN Names Johnson Assistant Dean, Diversity & Inclusion

Rolanda Johnson, PhD, MSN, assistant dean for academics and associate professor of nursing, has been named assistant dean for diversity and inclusion for Vanderbilt University School of Nursing. She replaces Assistant Professor Jana Lauderdale, who returned to her faculty role.

Read More

 
 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: